Elucidation of a potential role of poly-ADP-ribosylation in the carcinogenesis or development of human colorectal carcinoma and its application for the diagnosis or trteatment of human colorectal carcinoma

阐明聚-ADP-核糖基化在人结直肠癌发生或发展中的潜在作用及其在人结直肠癌诊断或治疗中的应用

基本信息

  • 批准号:
    18591456
  • 负责人:
  • 金额:
    $ 2.04万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Objective: Poly-adenosine 5'-diphosphate (ADP)-ribosylation, catalyzed by poly (ADP-ribose) polymerase (PARP), transfers poly-ADP-ribose moieties from nicotinamide adenine dinucleotide (NAD) to an acceptor protein. It is an important post-translational modification of nuclear proteins and is involved in various biological processes including malignant transformation. Thus, the aim of this study was to evaluate poly-ADP-ribosylation and to compare the expression of PARP in human colorectal carcinomas (CRCs) and adjacent non-tumorous mucosae.Methods: Tumorous and adjacent non-tumorous tissues were obtained from surgically removed colorectums of 15 patients with CRC, and then were homogenized into cytosolic and membranous fractions. Each homogenate was assayed for ADP-ribosylation with [adenylate-^<32> P] -NAD. The radiolabeled proteins were separated by electrophoresis and autoradiography. The ADP-ribosylated protein was partially purified by anion exchange column chromatography, and analyzed by time-of-flight mass spectrometry (TOF-MS) and immunoprecipitation. Expression of PARP was also evaluated by Western blotting.Results: Several proteins were ADP-ribosylated in human CRC tissues. Notably, the remarkable radiolabeling of a 113-kDa protein was found in the cytosolic fractions from CRCs, and greater than that in adjacent non-tumorous mucosae in 13/15 subjects (87 %). Inhibition assays revealed that the reaction was enzymatic poly-ADP-ribosylation. By TOF-MS and immunoprecipitation, the 113-kDa protein was found to be tumor rejection antigen, glycoprotein (gp) 96. The expression of PARP was significantly greater in CRCs than in adjacent non-tumorous mucosae, while the expression of gp96 in CRCs and normal mucosae was identical.Conclusion: Poly-ADP-ribosylation of gp 96 and PARP expression were increased in human CRCs compared with those in adjacent non-tumorous mucosae, and it may be implicated in the carcinogenesis or development of human CRC.
目的:聚腺苷核糖聚合酶(PARP)催化聚腺苷5‘-二磷酸(ADP)核糖化,将多聚腺苷核糖部分从烟酰胺腺嘌呤二核苷酸(NAD)转移到受体蛋白。它是核蛋白的一种重要的翻译后修饰,参与包括恶性转化在内的多种生物学过程。因此,本研究的目的是评估多聚ADP核糖化,并比较PARP在结直肠癌(CRC)和癌旁非肿瘤粘膜中的表达。方法:从15例结直肠癌患者手术切除的结直肠组织中获得肿瘤组织和邻近非肿瘤组织,然后将其匀浆为胞浆和膜部部分。每种匀浆均用[腺苷-32&gt;P]-NAD检测ADP核糖化。用凝胶电泳法和放射自显影技术分离标记的蛋白质。用阴离子交换柱层析对ADP核糖化蛋白进行部分纯化,并用飞行时间质谱仪(TOF-MS)和免疫沉淀进行分析。结果:在人结直肠癌组织中,有几种蛋白质被ADP核糖化。值得注意的是,在15名受试者中,有13名受试者(87%)在癌组织胞浆组分中发现了113 kDa蛋白质的显著放射性标记,且高于邻近非肿瘤粘膜中的标记。抑制实验表明,该反应为酶促多聚ADP核糖基化反应。经TOF-MS和免疫沉淀鉴定,该113 kDa蛋白为肿瘤排斥抗原糖蛋白(GP)96。PARP在癌组织中的表达明显高于癌旁非癌粘膜,而gp96在癌组织和正常粘膜中的表达无明显差异。结论:癌组织中gp 96的Poly-ADP核糖化和PARP的表达均高于癌旁非癌粘膜,可能与结直肠癌的发生发展有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhanced poly-(adenosine 5'-diphosphate)-ribosylation of glycoprotein 96 in human colorectal carcinoma
人结直肠癌中糖蛋白 96 的聚(腺苷 5-二磷酸)核糖基化增强
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nabeya;Y.;Inoue;M.;Yahiro;K.;Morinaga;N.;Sakamoto;A.;Noda;M. and Ochiai;T.
  • 通讯作者:
    T.
Enhanced poly-(adenosine 5'-diphosphate)-ribosylation of glycoprotein 96 in human colorectal carcinoma.
人结直肠癌中糖蛋白 96 的聚(腺苷 5-二磷酸)核糖基化增强。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nabeya;Y.;Inoue;M.;et. al. (other 5 authors)
  • 通讯作者:
    et. al. (other 5 authors)
Identification of a protein which can receive poly-(adenosine 5'-diphosphate)-ribosylation in human colorectal carcinoma
人结直肠癌中可接受聚(腺苷5-二磷酸)-核糖基化的蛋白质的鉴定
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Inoue;M.;Nabeya;Y.;Yahiro;K;Akai;T.;Miyazaki;S.;Sakamoto;A.;Noda;M. and Ochiai;T.
  • 通讯作者:
    T.
Enhanced poly- (adenosine 5'-diphosphate) -ribosylation of glycoprotein 96 in human colorectal carcinoma
人结直肠癌中糖蛋白 96 的聚(腺苷 5-二磷酸)-核糖基化增强
ヒト大腸癌においてpoly-ADP-ribosylationを受ける蛋白の同定
人类结直肠癌中进行聚 ADP 核糖基化的蛋白质的鉴定
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    井上雅仁;鍋谷圭宏;ほか6名
  • 通讯作者:
    ほか6名
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NABEYA Yoshihiro其他文献

NABEYA Yoshihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NABEYA Yoshihiro', 18)}}的其他基金

Genome analysis of esophageal cancer by next generation sequencer aiming for appropriately-individualized treatment
通过新一代测序仪对食管癌进行基因组分析,以实现适当的个体化治疗
  • 批准号:
    26462001
  • 财政年份:
    2014
  • 资助金额:
    $ 2.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of the regulation of thymidylate synthase levels associated with response to 5-fluorouracil in human gastric cancer cells
人胃癌细胞中胸苷酸合酶水平与5-氟尿嘧啶反应相关的调节机制
  • 批准号:
    20591562
  • 财政年份:
    2008
  • 资助金额:
    $ 2.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
STUDIES OF POSTOPERATIVE ADJUVANT CHEMOTHERAPY BASED ON THE PREDICTION OF EFFICACY OF 5-FU-BASED CHEMOTHERAPY FOR GASTRIC CANCER.
基于 5-FU 胃癌化疗疗效预测的术后辅助化疗研究。
  • 批准号:
    12671199
  • 财政年份:
    2000
  • 资助金额:
    $ 2.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了